Your session is about to expire
← Back to Search
The Effects of a Nature-Based Mindfulness-Compassion Intervention for Older Adults Delivered Using Virtual Reality
N/A
Waitlist Available
Led By Bassam Khoury, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline (week 1), mid-point (week 3), post-intervention (week 5) and follow-up (week 9)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a VR program called 'Toujours Dimanche' designed to improve mental health in older adults. Participants use VR headsets to experience nature and guided meditation sessions regularly. The goal is to see if this immersive experience can reduce stress and improve well-being.
Eligible Conditions
- Healthy Aging
- Mental Health Wellness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline (week 1), mid-point (week 3), post-intervention (week 5) and follow-up (week 9)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline (week 1), mid-point (week 3), post-intervention (week 5) and follow-up (week 9)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline in Scores on the Flourishing Scale (FS)
Change from Baseline in Scores on the General Self-Efficacy Scale (GSE)
Change from Baseline in Scores on the Perceived Stress Scale (PSS)
+1 moreSecondary study objectives
Change from Baseline in Scores on the Connectedness to Nature Scale (CNS)
Change from Baseline in Scores on the Embodied Mindfulness Questionnaire (EMQ)
Change from Baseline in Scores on the Five Facet Mindfulness Questionnaire-Short Form (FFMQ-24)
+1 moreOther study objectives
Change from Time 1 in Scores on the Simulator Sickness Questionnaire (SSQ)
Researcher Developed Virtual Reality Program Satisfaction Questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality (VR) MeditationExperimental Treatment1 Intervention
The VR Meditation intervention will be administered in Arm 1.
Group II: Psychoeducational PamphletsActive Control1 Intervention
The Psychoeducation Pamphlet intervention will be administered in Arm 2.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality (VR) Meditation
2022
N/A
~30
Find a Location
Who is running the clinical trial?
McGill UniversityLead Sponsor
414 Previous Clinical Trials
1,018,656 Total Patients Enrolled
1 Trials studying Healthy Aging
93 Patients Enrolled for Healthy Aging
Super Sublime | Super SplendideUNKNOWN
Résidences EnharmonieUNKNOWN
Bassam Khoury, PhDPrincipal InvestigatorMcGill University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have experienced frequent migraines, seizures, or head injuries in the last year.You have recently had eye surgery or suffer from glaucoma.You have been diagnosed with epilepsy or severe vertigo.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual Reality (VR) Meditation
- Group 2: Psychoeducational Pamphlets
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.